Cargando…
New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor for cardiovascular diseases (CVD), leading to a high mortality rate in gen...
Autores principales: | Su, Xin, Peng, Dao-quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769531/ https://www.ncbi.nlm.nih.gov/pubmed/29334984 http://dx.doi.org/10.1186/s12944-018-0659-y |
Ejemplares similares
-
ANGPLT3: A novel modulator of lipid metabolism
por: Hassan, Mohamed
Publicado: (2017) -
New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients
por: Su, Xin, et al.
Publicado: (2018) -
New insights into the mechanism of low high-density lipoprotein cholesterol in obesity
por: Wang, Hao, et al.
Publicado: (2011) -
Lipoprotein Metabolism Indicators Improve Cardiovascular Risk Prediction
por: van Schalkwijk, Daniël B., et al.
Publicado: (2014) -
Editorial: Beyond Cardiovascular Disease: Challenging New Pathways in Lipid and Lipoprotein Metabolism
por: Passarelli, Marisa, et al.
Publicado: (2022)